Clinical trials
Placebo clinical trials
Below are recruiting placebo clinical trials, each written for real people, not researchers. We’re tracking 5,158 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06723444Recruiting
Improving Memory in Portuguese Patients with Multiple Sclerosis
This study tests a new method to improve memory and learning in people with multiple sclerosis who have mild memory problems. You'll undergo memory training and assessments to see if it helps.
PortoAges 18–70 - NCT07412132RecruitingPhase 3
Testing lacosamide for hard-to-treat bipolar depression
This study tests if a medication called lacosamide can help people with bipolar depression that has not improved with at least two other treatments. It's for those with moderate to severe depression in bipolar I or II.
São Paulo, São PauloAges 18–65 - NCT07408193RecruitingEarly Phase 1
Lidocaine and ketamine for severe cancer pain not helped by opioids
This trial tests if adding lidocaine and ketamine to your current pain medicines can better control severe cancer-related pain that opioids alone haven't helped.
Athens, AtticaAges 18 years+ - NCT07409714RecruitingEarly Phase 1
Montelukast for kidney and heart health in young adults with type 2 diabetes
This trial tests if montelukast, a common asthma medication, can help protect the kidneys and heart in adolescents and young adults with type 2 diabetes. It looks at how the drug affects markers of kidney function and blood vessel health over time.
Aurora, ColoradoAges 14–24 - NCT07415707Recruiting
Reducing alcohol and taking probiotics for brain health in older adults
This study tests whether cutting back on alcohol and taking probiotics can improve memory and thinking in older adults who are heavy drinkers. If you are interested in drinking less, you may be able to join.
Miami, FloridaAges 65–84 - NCT07415720Recruiting
Artichoke and Mediterranean diet to prevent type 2 diabetes
This study tests whether a special extract from artichoke by-products, combined with a Mediterranean diet, can help prevent type 2 diabetes in people who are at risk. It aims to improve how your body handles sugar and insulin.
Pamplona, NavarreAges 18–75 - NCT07415655RecruitingPhase 2
Albumin for stroke in the front of the brain
This trial tests whether giving albumin (a protein naturally in your blood) can help protect your brain after an ischemic stroke in the front part of your brain. You need to be planning a procedure to open the blocked vessel.
Hradec Králové, Czech RepublicAges 18 years+ - NCT07409753RecruitingPhase 2
How oxytocin affects nerve signals in healthy women
This study tests how a single dose of oxytocin affects nerve signals in your arm. It helps researchers understand how oxytocin might change the way your body senses touch or pain.
LinköpingAges 18–65 - NCT07413744RecruitingPhase 1
Gut health and probiotics study for memory concerns
This study looks at how a probiotic supplement affects the gut and thinking in older adults, including those with mild cognitive impairment or Alzheimer's. It may help explain if improving gut health can support brain health.
Madison, WisconsinAges 60 years+ - NCT05790655Recruiting
Platelet-rich ovarian treatment for low egg reserve
This trial tests whether platelet-rich plasma (PRP) can improve fertility outcomes in people with low egg reserve. It may help if you are in the right age range and have been diagnosed with diminished ovarian reserve or poor ovarian response.
New York, New YorkAges 35–42 - NCT06262594RecruitingPhase 3
Testing a sleep medicine for epilepsy-related insomnia
This study tests a new sleep medicine called lemborexant for people with epilepsy whose seizures happen during sleep and who also have trouble sleeping. The goal is to see if the medicine can help you sleep better without making your seizures worse.
Durham, North CarolinaAges 18 years+ - NCT06754605RecruitingPhase 1/Phase 2
Testing a new RSV vaccine for safety and immune response
This trial tests a new RSV vaccine in two phases. First, it will be given to healthy adults 18 and older to check safety. Then, it will be studied in adults 50 and older, including those with stable health conditions, to see if it helps protect against RSV, a common virus that can cause serious breathing problems in older people.
Langfang, HebeiAges 18–120 - NCT06825013RecruitingPhase 4
Bronchodilators and exercise in COPD
This study tests how a bronchodilator (a medicine that opens airways) affects breathing and exercise in people with COPD. It aims to understand if it helps you breathe easier during physical activity.
Kingston, OntarioAges 40 years+ - NCT07400965RecruitingPhase 2
Testing a new eye drop for eyelid inflammation caused by tiny mites
This trial tests an investigational eye drop (GLK-321) to see if it safely and effectively treats Demodex blepharitis, an eyelid inflammation caused by tiny mites. It may help people who have signs of this condition and good enough vision.
Newport Beach, CaliforniaAges 18 years+ - NCT07402213RecruitingPhase 3
Study of JYB1904 for chronic spontaneous urticaria
This trial tests a new injectable medicine (JYB1904) to see if it can reduce itching and hives better than standard antihistamines alone. If you have chronic hives with no clear cause and still get symptoms despite taking antihistamines, this study may be an option for you.
BeijingAges 18 years+ - NCT07399171RecruitingPhase 2
Testing HT-4253 to prevent Alzheimer's in APOE4 carriers
This trial tests an experimental drug called HT-4253 to see if it can prevent Alzheimer's disease in people who are at higher genetic risk (carry the APOE4 gene) and have early signs of amyloid buildup in the brain. If you qualify, you would take the drug or a placebo and be monitored over time.
Abu Dhabi, Abu Dhabi EmirateAges 50–75 - NCT07402369RecruitingPhase 2
Testing CMS-D002 for heavy bleeding from uterine fibroids
This trial tests a capsule called CMS-D002 for heavy periods caused by uterine fibroids. It might help reduce your bleeding if you have fibroids at least 2 cm in size, regular cycles, and are between 18 and 50.
Beijing, Beijing MunicipalityAges 18–50 - NCT07400003RecruitingPhase 1/Phase 2
Shingles mRNA vaccine safety and immune response study
This trial tests a new mRNA vaccine to prevent shingles (herpes zoster). It checks if the vaccine is safe and helps your body build immunity. It's for adults aged 40 or older (phase 1) or 50+ (phase 2).
XinjiangAges 40 years+ - NCT07398417RecruitingPhase 3
Testing esreboxetine for fibromyalgia relief
This study tests a medicine called esreboxetine to see if it helps people with fibromyalgia. First, everyone gets the medicine, then some may switch to a placebo to see if the medicine keeps working better than no treatment.
Glendale, ArizonaAges 18 years+ - NCT07405814Recruiting
Testing a new treatment for high cholesterol
This trial tests a new medicine, Artisterol, to see if it can lower cholesterol in people with mildly high levels. It may be an option if you haven't tried other treatments or can't take statins.
LodzAges 18–70 - NCT07403487RecruitingPhase 2
Study of RC1416 injection for moderate-to-severe asthma
This study tests a new injected medicine, RC1416, for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It aims to see if the treatment can reduce asthma attacks and improve breathing.
Anqing, AnhuiAges 18–75 - NCT07403266RecruitingPhase 3
Full-spectrum cannabis oil for seizures in tuberous sclerosis
This trial tests a full-spectrum cannabis extract to see if it reduces seizures in people with tuberous sclerosis complex (TSC) whose seizures have not been controlled by other treatments. If it works, it could offer a new option for managing hard-to-treat epilepsy.
MadridAges 2–65 - NCT07402382Recruiting
Chromium blend study for women in menopause transition
This trial tests whether a special chromium supplement can help the body process protein and sugar better in women going through or past menopause. You'll follow a controlled diet and have blood draws to measure how your body responds.
Canfield, OhioAges 40–70 - NCT07406035RecruitingPhase 2
Study of TQH3906 for active psoriatic arthritis
This trial tests an experimental oral medication called TQH3906 for people with active psoriatic arthritis (PsA), a condition that causes joint pain, swelling, and skin psoriasis. The study aims to see if TQH3906 is safe and effective in reducing arthritis symptoms.
Bozhou, AnhuiAges 18–70
Hear when a new Placebo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo?
- Yes. Clin2 currently lists 5,158 recruiting placebo studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.